| Literature DB >> 26030210 |
Xiao-Ran Yan1, Wan-Zhen Jiao1, Zhi-Wei Li1, Wen-Wen Xu1, Feng-Jiao Li1, Li-Hua Wang1.
Abstract
PURPOSE: To assess the accuracy of the Plusoptix A09 photoscreener in detecting amblyopia risk factors in children and determine referral criteria when using Plusoptix A09 for a large-scale vision screening.Entities:
Mesh:
Year: 2015 PMID: 26030210 PMCID: PMC4452218 DOI: 10.1371/journal.pone.0126052
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1(A) Distribution of ages of the study subjects; (B) Distribution of refractive errors of the study subjects.
The mean spherical equivalent (SE) and Jackson cross cylinder power values obtained by the Plusoptix A09 and cycloplegic retinoscopy.
| Mean SE value (D) | Mean cylinder power value J0 (D) | Mean cylinder power value J45 (D) | |
|---|---|---|---|
| The Plusoptix A09 | 1.14 ± 2.19 | 0.05 ± 0.63 | -0.03 ± 0.70 |
| Cycloplegic retinoscopy | 1.71 ± 2.52 | -0.03 ± 0.51 | 0.05 ± 0.58 |
| P values | 0.00 | 0.14 | 0.26 |
*Paired t test
Fig 2Bland-Altman plots showing agreement between the Plusoptix A09 (Plus) and cycloplegic retinoscopy (CR) for SE, J0 and J45 values.
Fig 3The relationship between the results of the Plusoptix A09 and cycloplegic retinoscopy (three types of custom regression models including linear, quadratic and cubic regression).
Sensitivity and specificity for detecting refractive amblyopia risk factors with the Plusoptix A09 according to AAPOS.
| AAPOS criteria | Hyperopia>3.5 D in any meridian | Myopia>-3.0 D in any meridian | Astigmatism (>1.5 D within 10°of 90°or 180°,>1.0 D in oblique axis) | Anisometropia >1.5 D (spherical or cylindrical) |
|---|---|---|---|---|
| Sensitivity | 44.4% | 85.7% | 85.0% | 55.5% |
| Specificity | 97.7% | 94.7% | 85.5% | 87.9% |
Fig 4ROC curve for hyperopia obtained by the Plusoptix A09 in comparison with cycloplegic retinoscopy.
Fig 5ROC curve for anisometropia obtained by the Plusoptix A09 in comparison with cycloplegic retinoscopy.
Sensitivity and specificity for detecting refractive amblyopia risk factors with the Plusoptix A09 according to revised criteria on the basis of receiver operating characteristic (ROC) curve.
| Revised criteria | Hyperopia>1.88 D in any meridian | Myopia>-3.0 D in any meridian | Astigmatism (>1.5 D within 10°of 90°or180°,>1.0 D in oblique axis) | Anisometropia >1.25 D (spherical or cylindrical) |
|---|---|---|---|---|
| Sensitivity | 86.7% | 85.7% | 85.0% | 72.2% |
| Specificity | 89.5% | 94.7% | 85.5% | 84.8% |
Fig 6ROC curves of spherical and cylinder values obtained from the Plusoptix A09 in detecting amblyopia.
Sensitivity and specificity of the Plusoptix photoscreener in detecting refractive amblyopia risk factors with various referral criteria.
| Referral Criteria | Sensitivity | Specificity | |
|---|---|---|---|
| Plus manufacturer [ | 6–12 months Hyperopia≥3.0D, Myopia≥2.0D, Astigmatism≥1.0D, Anisometropia≥1.0D | 98% | 41% |
| 12–36 months Hyperopia≥1.0D, Myopia≥2.0D, Astigmatism≥0.75D, Anisometropia≥1.0D | |||
| 36–7 2months Hyperopia≥1.0D, Myopia≥1.0D, Astigmatism≥0.75D, Anisometropia≥1.0D | |||
| 72–240 months Hyperopia≥0.75D, Myopia≥0.75D, Astigmatism>0.75D, Anisometropia≥0.75D | |||
| AAPOS [ | Hyperopia>3.5D, Myopia>3.0D, Astigmatism>1.5D or >1.0D oblique axis, Anisometropia>1.5D | 74% | 86% |
| Arthur [ | Hyperopia>3.5D, Myopia>3.0D, Astigmatism>1.25D, Anisometropia>1.5D | 81% | 92% |
| Arthur2 [ | Hyperopia≥3.5D, Myopia≥3.0D, Astigmatism≥2.5D, Anisometropia≥1.5D | 67% | 96% |
| Arnold [ | 0–8 months Hyperopia≥3.0D, Myopia≥3.0D, Astigmatism≥2.0D, Anisometropia≥1.5D | 81% | 96% |
| 9–72 months Hyperopia≥2.5D, Myopia≥2.25D, Astigmatism≥2.0D, Anisometropia≥1.0D | |||
| 73–120 months Hyperopia≥2.0D, Myopia≥1.5D, Astigmatism≥1.5D, Anisometropia≥1.25D | |||
| PediaVision [ | 6–12 months Hyperopia≥3.5D, Myopia≥2.0D, Astigmatism≥2.25D, Anisometropia≥1.5D | 80% | 94% |
| 12–36 months Hyperopia≥3.0D, Myopia≥2.0D, Astigmatism≥2.0D, Anisometropia≥1.0D | |||
| 36–72 months Hyperopia≥2.5D, Myopia≥1.5D, Astigmatism≥1.5D, Anisometropia≥1.0D | |||
| 72–240 months Hyperopia≥2.5D, Myopia≥0.75D, Astigmatism>1.5D, Anisometropia≥1.0D | |||
| 240–1200 months Hyperopia≥1.5D, Myopia≥0.75D, Astigmatism>1.5D, Anisometropia≥1.0D | |||
| Matta/Silbert [ | 6–12 months Hyperopia≥3.0D, Myopia≥2.0D, Astigmatism≥1.0D, Anisometropia≥1.25D | 98% | 80% |
| 12–36 months Hyperopia≥1.25D, Myopia≥2.0D, Astigmatism≥1.0D, Anisometropia≥1.25D | |||
| 36–72 months Hyperopia≥1.25D, Myopia≥1.0D, Astigmatism≥1.0D, Anisometropia≥1.25D | |||
| 72–240 months Hyperopia≥1.0D, Myopia≥1.0D, Astigmatism>1.25D, Anisometropia≥1.25D |
Sensitivity and specificity of different vision screening techniques in detecting amblyopia, strabismus and refractive amblyopia risk factors.
| Vision Screeners | Amblyopia | Strabismus | Refractive risk factors | |||
|---|---|---|---|---|---|---|
| Sensitivity | Specificity | Sensitivity | Specificity | Sensitivity | Specificity | |
| Lea Symbols test [ | 0.76 | 0.90 | 0.56 | 0.90 | 0.70 | 0.90 |
| HOTV VA Test [ | 0.73 | 0.89 | 0.65 | 0.89 | 0.59 | 0.89 |
| Random Dot E stereoacuity [ | 0.63 | 0.90 | 0.60 | 0.90 | 0.47 | 0.90 |
| Noncycloplegic retinoscopy [ | 0.85 | 0.90 | 0.56 | 0.90 | 0.81 | 0.90 |
| MTI photoscreener [ | 0.63 | 0.94 | 0.65 | 0.94 | 0.42 | 0.94 |
| The Plusoptix A09 | 0.85 | 0.63 | 0.41 | 0.98 | 0.95 | 0.68 |